Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 301

1.

Regression of left ventricular hypertrophy and microalbuminuria changes during antihypertensive treatment.

Rodilla E, Pascual JM, Costa JA, Martin J, Gonzalez C, Redon J.

J Hypertens. 2013 Aug;31(8):1683-91. doi: 10.1097/HJH.0b013e328361461e.

PMID:
23835910
3.

Effects of angiotensin II receptor blockade-based therapy with losartan on left ventricular hypertrophy and geometry in previously treated hypertensive patients.

Cuspidi C, Meani S, Valerio C, Fusi V, Sala C, Maisaidi M, Zanchetti A.

Blood Press. 2006;15(2):107-15.

PMID:
16754274
4.

Left ventricular hypertrophy: how to influence an important risk factor in hypertension.

Agabiti-Rosei E, Muiesan ML.

J Hypertens Suppl. 1998 Jan;16(1):S53-8. Review.

PMID:
9534098
5.

Regression of echocardiographic left ventricular hypertrophy after 2 years of therapy reduces cardiovascular risk in patients with essential hypertension.

Pierdomenico SD, Lapenna D, Cuccurullo F.

Am J Hypertens. 2008 Apr;21(4):464-70. doi: 10.1038/ajh.2008.2. Epub 2008 Feb 7.

PMID:
18369364
6.

Nondipping pattern on 24-h ambulatory blood pressure monitoring is associated with left ventricular hypertrophy in chronic kidney disease.

Jaques DA, Müller H, Martinez C, De Seigneux S, Martin PY, Ponte B, Saudan P.

Blood Press Monit. 2018 Oct;23(5):244-252. doi: 10.1097/MBP.0000000000000337.

PMID:
29958233
7.

Suppression of aldosterone mediates regression of left ventricular hypertrophy in patients with hypertension.

Pouleur AC, Uno H, Prescott MF, Desai A, Appelbaum E, Lukashevich V, Smith BA, Dahlöf B, Solomon SD; ALLAY Investigators.

J Renin Angiotensin Aldosterone Syst. 2011 Dec;12(4):483-90. doi: 10.1177/1470320311414453. Epub 2011 Jul 11.

PMID:
21746765
8.

Left ventricular hypertrophy in non-insulin-dependent diabetic patients with and without diabetic nephropathy.

Nielsen FS, Ali S, Rossing P, Bang LE, Svendsen TL, Gall MA, Smidt UM, Kastrup J, Parving HH.

Diabet Med. 1997 Jul;14(7):538-46.

PMID:
9223391
9.

Microalbuminuria, left ventricular mass and ambulatory blood pressure in essential hypertension.

Redon J, Baldo E, Lurbe E, Bertolin V, Lozano JV, Miralles A, Pascual JM.

Kidney Int Suppl. 1996 Jun;55:S81-4.

PMID:
8743518
10.
11.
12.

Association of low-grade urinary albumin excretion with left ventricular hypertrophy in the general population: the MONICA/KORA Augsburg Echocardiographic Substudy.

Lieb W, Mayer B, Stritzke J, Doering A, Hense HW, Loewel H, Erdmann J, Schunkert H.

Nephrol Dial Transplant. 2006 Oct;21(10):2780-7. Epub 2006 Jul 31.

PMID:
16880179
13.

Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.

Okin PM.

J Electrocardiol. 2009 Nov-Dec;42(6):584-8. doi: 10.1016/j.jelectrocard.2009.06.020. Epub 2009 Jul 24.

PMID:
19631946
14.
15.
16.

Left Ventricular Hypertrophy Regression During Antihypertensive Treatment in an Outpatient Clinic (the Campania Salute Network).

Lønnebakken MT, Izzo R, Mancusi C, Gerdts E, Losi MA, Canciello G, Giugliano G, De Luca N, Trimarco B, de Simone G.

J Am Heart Assoc. 2017 Mar 8;6(3). pii: e004152. doi: 10.1161/JAHA.116.004152.

17.

Isolated ambulatory hypertension and changes in target organ damage in treated hypertensive patients.

Cuspidi C, Meani S, Fusi V, Valerio C, Catini E, Magrini F, Zanchetti A.

J Hum Hypertens. 2005 Jun;19(6):471-7.

PMID:
15744331
18.

Systematic review on urine albumin testing for early detection of diabetic complications.

Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C.

Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. Review.

19.

The deletion polymorphism of the angiotensin I-converting enzyme gene is associated with target organ damage in essential hypertension.

Pontremoli R, Sofia A, Tirotta A, Ravera M, Nicolella C, Viazzi F, Bezante GP, Borgia L, Bobola N, Ravazzolo R, Sacchi G, Deferrari G.

J Am Soc Nephrol. 1996 Dec;7(12):2550-8.

20.

Regression of left ventricular hypertrophy and prevention of stroke in hypertensive subjects.

Verdecchia P, Angeli F, Gattobigio R, Sardone M, Pede S, Reboldi GP.

Am J Hypertens. 2006 May;19(5):493-9.

PMID:
16647622

Supplemental Content

Support Center